Please wait while the formulary information is being retrieved.
PLEXION NS (sulfacetamide sodium)
- dandruff
- seborrheic dermatitis
9.8 % shampoo
- Apply by topical route twice weekly to wet hair, massage vigorously into scalp and, then rinse thoroughly
Default screening record
- Apply by topical route twice weekly to wet hair, massage vigorously into scalp and, then rinse thoroughly
- None
Contraindicated
- Silvadene
- silver sulfadiazine
- Ssd
- Thermazene
Severe
Moderate
- None
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemolytic anemia from pyruvate kinase and g6PD deficienc
Contraindicated
- None
Severe
Moderate
- None
PLEXION NS (sulfacetamide sodium)
- dandruff
- seborrheic dermatitis
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Agranulocytosis
- Blood dyscrasias
- Erythema
- Glucose-6-phosphate dehydrogenase deficiency anemia
- Hepatic necrosis
- Hypersensitivity drug reaction
- Pruritus of skin
- Skin irritation
- Skin rash
- Stevens-johnson syndrome
- Systemic lupus erythematosus
- Toxic epidermal necrolysis
Less Severe
- None
Contraindicated
Sulfacetamide Sodium (Top)
Not recommended in infants under 2 months. May cause kernicterus.
- 1 Day – 59 Days
- 1 Not recommended in infants under 2 months. May cause kernicterus.
Severe Precaution
None
Management or Monitoring Precaution
None
Sulfacetamide Sodium (ophth & Top)
- Severity Level:
C
- Additional Notes: Insufficient human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Sulfacetamide (ophth, Top, Vag)
Absorp unknown;Kernicterus risk in newborn;Sulfas not rec if g6Pd def infant
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Absorp unknown;Kernicterus risk in newborn;Sulfas not rec if g6Pd def infant |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Dandruff | |
| L21.0 | Seborrhea capitis |
| Seborrheic dermatitis | |
| L21 | Seborrheic dermatitis |
| L21.0 | Seborrhea capitis |
| L21.1 | Seborrheic infantile dermatitis |
| L21.8 | Other seborrheic dermatitis |
| L21.9 | Seborrheic dermatitis, unspecified |
| 0-9 | A-Z |
|---|---|
| L21 | Seborrheic dermatitis |
| L21.0 | Seborrhea capitis |
| L21.0 | Seborrhea capitis |
| L21.1 | Seborrheic infantile dermatitis |
| L21.8 | Other seborrheic dermatitis |
| L21.9 | Seborrheic dermatitis, unspecified |
Formulary Reference Tool